Nonerythropoietic Erythropoietin-Derived Peptide Suppresses Adipogenesis, Inflammation, Obesity and Insulin Resistance

Erythropoietin (EPO) has been identified as being crucial for obesity modulation; however, its erythropoietic activity may limit its clinical application. EPO-derived Helix B-surface peptide (pHBSP) is nonerythrogenic but has been reported to retain other functions of EPO. The current study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuqi, Luo, Bangwei, Shi, Rongchen, Wang, Jinsong, Liu, Zongwei, Liu, Wei, Wang, Shufeng, Zhang, Zhiren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602313/
https://www.ncbi.nlm.nih.gov/pubmed/26459940
http://dx.doi.org/10.1038/srep15134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602313/
https://www.ncbi.nlm.nih.gov/pubmed/26459940
http://dx.doi.org/10.1038/srep15134

Ejemplares similares